11.5 Reporting High-Exposure Cases and Aggregate Claims Experience

Reporting High-Exposure Cases and Aggregate Claims Experience

Domain 5 asks the risk manager to "inform administration of high exposure cases and aggregate claims experience, including any impact to the risk financing program." This is the task that closes the loop. Everything upstream - identifying the potentially compensable event, notifying the carrier, evaluating exposure, resolving the claim - generates information that creates value only if it reaches the people who set budgets, buy insurance, and govern quality.

Two distinct streams live inside this task, and the exam tests them differently.

• The single high-exposure case report - episodic, urgent, deeply privileged, tightly distributed.
• The aggregate claims experience report - periodic, analytic, board-facing, and the direct input to next year's risk financing decisions.

Confusing the two is the classic failure. A candid case narrative belongs in a privileged channel with a named, minimal audience. A trend dashboard belongs in the board packet. Pushing case narratives into board packets manufactures discoverable admissions; withholding aggregate trends from the board leaves a governing body surprised by a premium and collateral increase it could have anticipated a year earlier.

Escalation criteria belong in policy, not in judgment

Do not decide case by case who deserves a call at nine o'clock at night. Write the triggers into the risk management plan and claims policy, have them approved at the board committee level, and apply them mechanically. The exam rewards the answer in which notification follows pre-defined criteria, not the answer in which the risk manager personally decides whether leadership would want to know.

Triggers that should compel immediate executive notification, and at defined thresholds board notification:

• Catastrophic patient harm - neurologic injury to a newborn, maternal death, wrong-site or wrong-patient surgery, unanticipated death, permanent disabling injury, or any event meeting the accrediting body's sentinel event definition.
• Financial reach - a claim credibly reserved to pierce the self-insured retention, to approach or exceed a policy limit, or to trigger an excess or reinsurance layer.
• Uninsurable or coverage-threatening exposure - punitive damages, alleged intentional or criminal conduct, a reservation of rights, a coverage dispute, or a potential bad-faith issue with the organization's own carrier.
• Individual jeopardy - licensure action, criminal investigation, or program exclusion exposure for a practitioner or employee.
• Institutional profile - a named senior leader, a department chair or high-volume practitioner, a research subject, an employee treated as a patient, or a public figure.
• Public exposure - media inquiry, social media escalation, legislative or regulatory attention.
• Multiplicity - class actions and multi-claimant events such as a device recall, a sterilization or reprocessing failure, a diverting clinician who exposed many patients, or a data breach. These behave differently from single claims because each additional claimant multiplies indemnity and consumes a shared aggregate limit.
• Any matter requiring a coverage decision, because acting before that decision can prejudice coverage.

The high-exposure case report

Keep it factual, current, and short enough that busy executives actually read it. Contents:

1. Identifying data - claim number, claimant, date of loss, date of report, facility and service line, involved practitioners and their coverage status.
2. A neutral factual chronology - what happened and in what order, sourced to the record.
3. Legal posture - pre-suit or suit filed, venue, plaintiff counsel, assigned defense counsel, key upcoming dates.
4. The evaluation - liability assessment, damages range, and the current reserve with the basis for any change since the last report.
5. Coverage position - which policies respond, the retention, attaching layers, and any reservation of rights.
6. The resolution plan and the specific decision requested - authority to mediate, authority to settle to a stated figure, or approval to try the case.
7. Corrective action taken and its status, so leadership hears mitigation alongside exposure rather than exposure alone.

Conveying it without waiving privilege

A candid, widely circulated memo is a gift to the plaintiff. The protective habits:

• Route through counsel. Prepare the analysis at the direction of in-house or outside counsel so that attorney-client and work-product protections have a factual foundation. The document must genuinely be a legal communication or work prepared in anticipation of litigation.
• Label accurately and consistently - for example, Privileged and Confidential: Attorney-Client Communication and Attorney Work Product, Prepared at the Direction of Counsel. A stamp alone creates nothing.
• Control distribution. Named recipients with a genuine need to know. No distribution lists, no forwarding, no attaching the memo to a board packet emailed to personal accounts. Every recipient outside the privileged circle supplies a waiver argument.
• Separate privileged analysis from operational content. A single document mixing candid legal evaluation with routine business reporting risks losing protection for the whole thing; keep the legal analysis in a separate, properly labeled attachment.
• Brief the board in executive session with counsel present, and record in the minutes only that a privileged report on pending litigation was received - never a summary of its substance.
• Discipline the writing itself. Do not speculate about fault in writing, do not predict defeat in an email, and do not conduct settlement authority discussions in operational channels.
• Know that the protections are distinct. Attorney-client privilege, work product, state peer review protection, and federal patient safety work product under a patient safety organization arrangement each have their own requirements and their own gaps; a document that fails one is not automatically rescued by another. The privilege section covers the doctrine in depth. The operating rule here is that privilege is built by process, not by a label.

The aggregate claims experience report

This report goes to the board's quality, audit, finance, or combined risk committee on a defined cycle - commonly quarterly, with a fuller annual review timed ahead of renewal. It is analytic and de-identified, built to show direction rather than to relitigate individual cases.

Always present frequency and severity separately, because they move independently and demand different responses. Rising frequency concentrated in one service line is a patient safety problem calling for clinical intervention. Flat frequency with rising severity is a risk financing problem calling for a limits adequacy review. The underlying trending mechanics - loss triangles, development factors, and incurred-but-not-reported estimates - belong to the loss run and actuarial sections; what the risk manager owes the board here is the interpretation and the recommended response.

The risk financing feedback loop: forecast before renewal, not after

This is the portion of the task candidates skip, and the blueprint names it explicitly. Claims experience is the primary input to the cost and structure of next year's program.

• Renewal pricing. Underwriters price on roughly five years of loss runs plus exposure data. Adverse development in the most recent years hits hardest, because it suggests the deterioration is live rather than historical.
• Retention level. Rising frequency of modest claims argues for absorbing more inside the retention; rising severity argues for buying more limit rather than more retention. Every retention increase lowers premium and shifts cash volatility onto the operating budget, which is a decision for finance, not a purchasing convenience.
• Limits adequacy. If severity is trending and the market is producing outsized verdicts, a tower purchased three years ago may no longer reach far enough. A limits adequacy study run against the organization's own severity distribution answers the question with data instead of instinct.
• Collateral. Fronted programs, large-deductible programs, and captives require collateral - typically a letter of credit or a funded trust - sized to unpaid loss estimates. Deteriorating development raises the collateral demand, and a letter of credit consumes bank capacity the health system would rather spend on capital projects. This is the impact chief financial officers most dislike learning about late.
• Actuarial funding confidence level. Retained losses are funded at a selected confidence level: the expected or mean estimate, or a higher percentile such as the 75th or 80th for a margin. Worsening experience widens the loss distribution, so maintaining the same confidence level costs more money even when the expected loss is unchanged.
• Captive capitalization. A captive's surplus must support its written premium and reserves to the satisfaction of its domicile regulator. Adverse development can require a capital contribution from the parent and can affect the actuary's statement of opinion.

Timing rule. Build the forecast before the renewal cycle, not after the quote arrives. A workable cadence is to value loss runs and complete the actuarial study roughly 120 to 180 days before expiration, brief finance at that point on projected premium, retention, limit, and collateral impacts, and give the broker a submission containing current valued loss runs, accurate exposure data, and a written narrative of the corrective actions taken on the identified loss drivers. That narrative is the risk manager's leverage: underwriters price uncertainty, and documented remediation reduces it.

Coordinating with finance and the auditors

Claims liabilities appear on the financial statements, so the risk manager is a source of information for accounting judgments rather than merely a reporter of operational data. At a conceptual level:

• A loss contingency is accrued when a loss is probable and the amount is reasonably estimable, and is disclosed without accrual when a material loss is reasonably possible but does not meet both accrual conditions.
• Health care entities record estimated professional liability obligations including incurred-but-not-reported claims, and present that liability gross, showing any anticipated insurance recovery as a separate asset rather than netting it against the liability.
• The actuarial study supports management's estimate, and external auditors, often using their own actuarial specialists, test it and will ask about large open claims and reserve adequacy.

The risk manager supplies accurate claim data and current evaluations to finance on schedule, and flags matters that could move the accrual, while letting accounting make the accounting judgment. Two boundaries matter. Do not let a desire to keep reserves stable suppress an honest evaluation. And do not circulate reserve figures outside the privileged and financial channels - a reserve is a funding estimate rather than an admission of value, but a plaintiff will argue otherwise if the number surfaces.

Candor to the board versus discoverability

The board needs enough information to govern. The plaintiff would love the same document. The answer is not to tell the board less; it is to tell the board through the correct channel.

• Aggregate, de-identified trend reporting belongs in the regular packet. It is business information, largely discoverable, and should be written so that any reader can see it without harm.
• Case-specific candid evaluation belongs in counsel-directed, privileged, executive-session reporting with controlled distribution.
• Never write an unprivileged candid case narrative so that the board understands the details. That single act converts a governance obligation into a trial exhibit.

Scenario

A health system's claims data show flat frequency over three years, severity per closed claim up 60%, adverse reserve development in the two most recent years, and one open birth injury case reserved above the retention. The renewal is five months away. The risk manager delivers three separate products: a privileged, counsel-directed case report on the birth injury case to the executive team with a briefing for the board committee in executive session; a de-identified quarterly dashboard to the board committee showing frequency, severity, closure outcomes, and total cost of risk; and a forecast memo to the chief financial officer projecting the premium, retention, limit, and collateral consequences of the severity trend, supported by the actuarial study and accompanied by the corrective-action narrative that will go into the underwriting submission.

Exam traps

• Reporting a case narrative in the open session quality report so the board is informed.
• Waiting for the next scheduled meeting when a written escalation trigger has already fired.
• Telling finance about the collateral and funding impact after the renewal quote arrives.
• Presenting paid losses only, which understates the program by ignoring outstanding reserves and unreported claims.
• Presenting a single combined loss number without separating frequency from severity, which hides which lever to pull.
• Stamping a memo privileged and emailing it to forty managers.
• Assuming peer review protection covers a claims report prepared for the board.
• Softening or removing an adverse development figure to avoid alarming the board, which is both a fiduciary failure and the fastest way to lose credibility when the renewal arrives.